These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mitochondria-penetrating peptides: sequence effects and model cargo transport. Yousif LF; Stewart KM; Horton KL; Kelley SO Chembiochem; 2009 Aug; 10(12):2081-8. PubMed ID: 19670199 [TBL] [Abstract][Full Text] [Related]
3. Targeting mitochondria with organelle-specific compounds: strategies and applications. Yousif LF; Stewart KM; Kelley SO Chembiochem; 2009 Aug; 10(12):1939-50. PubMed ID: 19637148 [TBL] [Abstract][Full Text] [Related]
4. Tuning the activity of mitochondria-penetrating peptides for delivery or disruption. Horton KL; Pereira MP; Stewart KM; Fonseca SB; Kelley SO Chembiochem; 2012 Feb; 13(3):476-85. PubMed ID: 22238158 [TBL] [Abstract][Full Text] [Related]
5. Cell-penetrating peptides are excluded from the mitochondrial matrix. Ross MF; Murphy MP Biochem Soc Trans; 2004 Dec; 32(Pt 6):1072-4. PubMed ID: 15506968 [TBL] [Abstract][Full Text] [Related]
6. Transduction peptides: from technology to physiology. Joliot A; Prochiantz A Nat Cell Biol; 2004 Mar; 6(3):189-96. PubMed ID: 15039791 [TBL] [Abstract][Full Text] [Related]
7. Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria. Jean SR; Ahmed M; Lei EK; Wisnovsky SP; Kelley SO Acc Chem Res; 2016 Sep; 49(9):1893-902. PubMed ID: 27529125 [TBL] [Abstract][Full Text] [Related]
8. Development of novel peptides for mitochondrial drug delivery: amino acids featuring delocalized lipophilic cations. Kelley SO; Stewart KM; Mourtada R Pharm Res; 2011 Nov; 28(11):2808-19. PubMed ID: 21833796 [TBL] [Abstract][Full Text] [Related]
9. Transport and accumulation of lipophilic dye cations at the mitochondria of HeLa cells in situ. Röttele J; Zimmermann HW Cell Mol Biol (Noisy-le-grand); 1993 Nov; 39(7):739-56. PubMed ID: 7505674 [TBL] [Abstract][Full Text] [Related]
10. Studying the uptake of cell-penetrating peptides. Holm T; Johansson H; Lundberg P; Pooga M; Lindgren M; Langel U Nat Protoc; 2006; 1(2):1001-5. PubMed ID: 17406337 [TBL] [Abstract][Full Text] [Related]
11. The engineering of membrane-permeable peptides. Carrigan CN; Imperiali B Anal Biochem; 2005 Jun; 341(2):290-8. PubMed ID: 15907875 [TBL] [Abstract][Full Text] [Related]
12. Engineered apoptosis-inducing peptides with enhanced mitochondrial localization and potency. Horton KL; Kelley SO J Med Chem; 2009 May; 52(10):3293-9. PubMed ID: 19397319 [TBL] [Abstract][Full Text] [Related]
13. Mitochondrial targeting of a cationic amphiphilic polyproline helix. Kalafut D; Anderson TN; Chmielewski J Bioorg Med Chem Lett; 2012 Jan; 22(1):561-3. PubMed ID: 22130131 [TBL] [Abstract][Full Text] [Related]